SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $13.60 million. The enterprise value is $6.77 million.
| Market Cap | 13.60M |
| Enterprise Value | 6.77M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 4.41 million shares outstanding. The number of shares has increased by 393.33% in one year.
| Current Share Class | 4.41M |
| Shares Outstanding | 4.41M |
| Shares Change (YoY) | +393.33% |
| Shares Change (QoQ) | +4.24% |
| Owned by Insiders (%) | 1.04% |
| Owned by Institutions (%) | 3.65% |
| Float | 4.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.59 |
| Forward PS | 13.00 |
| PB Ratio | 2.93 |
| P/TBV Ratio | 3.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.89 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -518.11 |
Financial Efficiency
Return on equity (ROE) is -356.87% and return on invested capital (ROIC) is -225.02%.
| Return on Equity (ROE) | -356.87% |
| Return on Assets (ROA) | -102.67% |
| Return on Invested Capital (ROIC) | -225.02% |
| Return on Capital Employed (ROCE) | -325.63% |
| Weighted Average Cost of Capital (WACC) | -1.23% |
| Revenue Per Employee | $95,167 |
| Profits Per Employee | -$757,056 |
| Employee Count | 18 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, ICU has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.56% in the last 52 weeks. The beta is -1.03, so ICU's price volatility has been lower than the market average.
| Beta (5Y) | -1.03 |
| 52-Week Price Change | -63.56% |
| 50-Day Moving Average | 3.65 |
| 200-Day Moving Average | 3.26 |
| Relative Strength Index (RSI) | 43.02 |
| Average Volume (20 Days) | 56,701 |
Short Selling Information
The latest short interest is 121,687, so 2.76% of the outstanding shares have been sold short.
| Short Interest | 121,687 |
| Short Previous Month | 91,177 |
| Short % of Shares Out | 2.76% |
| Short % of Float | 2.79% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
In the last 12 months, ICU had revenue of $1.71 million and -$13.63 million in losses. Loss per share was -$3.81.
| Revenue | 1.71M |
| Gross Profit | 1.59M |
| Operating Income | -13.99M |
| Pretax Income | -13.62M |
| Net Income | -13.63M |
| EBITDA | n/a |
| EBIT | -13.99M |
| Loss Per Share | -$3.81 |
Balance Sheet
The company has $6.96 million in cash and $134,000 in debt, with a net cash position of $6.83 million or $1.55 per share.
| Cash & Cash Equivalents | 6.96M |
| Total Debt | 134,000 |
| Net Cash | 6.83M |
| Net Cash Per Share | $1.55 |
| Equity (Book Value) | 4.30M |
| Book Value Per Share | 1.01 |
| Working Capital | 3.88M |
Cash Flow
| Operating Cash Flow | -13.69M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 120,000 |
| Free Cash Flow | -13.69M |
| FCF Per Share | -$3.11 |
Margins
| Gross Margin | 92.64% |
| Operating Margin | -816.64% |
| Pretax Margin | -795.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -393.33% |
| Shareholder Yield | -393.33% |
| Earnings Yield | -104.82% |
| FCF Yield | -105.33% |
Analyst Forecast
The average price target for ICU is $10.00, which is 224.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 224.15% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (3Y) | 134.93% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 5, 2026. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 5, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ICU has an Altman Z-Score of -28.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.31 |
| Piotroski F-Score | 2 |